Cellectis (CLLS) Cash & Equivalents: 2014-2023
Historic Revenue - Interest and Investment Income for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to $209.7 million.
- Cellectis' Revenue - Interest and Investment Income fell 24.99% to $209.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $950.0 million, marking a year-over-year decrease of 28.56%. This contributed to the annual value of $261.2 million for FY2022, which is 31.63% down from last year.
- Cellectis' Cash & Equivalents amounted to $67.4 million in Q3 2023, which was down 20.18% from $84.4 million recorded in Q2 2023.
- Cellectis' Cash & Equivalents' 5-year high stood at $421.5 million during Q1 2019, with a 5-year trough of $67.4 million in Q3 2023.
- For the 3-year period, Cellectis' Cash & Equivalents averaged around $142.2 million, with its median value being $129.4 million (2022).
- Per our database at Business Quant, Cellectis' Revenue - Interest and Investment Income spiked by 57.98% in 2019 and then plummeted by 32.29% in 2022.
- Quarterly analysis of 5 years shows Cellectis' Revenue - Interest and Investment Income stood at $467.5 million in 2019, then climbed by 0.43% to $469.5 million in 2020, then decreased by 18.62% to $382.1 million in 2021, then plummeted by 31.63% to $261.2 million in 2022, then declined by 24.99% to $209.7 million in 2023.
- Its Revenue - Interest and Investment Income was $209.7 million in Q3 2023, compared to $227.7 million in Q2 2023 and $251.4 million in Q1 2023.